A Smarter Brain Implant Could Finally Help Parkinson's Patients Walk With More Confidence

Conventional deep brain stimulation (DBS) has long been an effective treatment for many of the hallmark symptoms of Parkinson's disease, including tremor, rigidity and slowness of movement in the arms and legs. But according to Doris Wang, M.D., Ph.D., a neurosurgeon at the University of California, San Francisco, who specializes in movement disorder surgery, conventional DBS has a significant blind spot: gait, balance and falls.

The reason, Wang explains, comes down to how traditional DBS works. It delivers continuous, fixed-rate stimulation that suppresses the abnormal brain rhythms associated with Parkinson's, effectively freeing patients to move more easily. That approach works well for symptoms that are relatively stable. Walking is not one of them.

Gait is a highly dynamic process requiring constant coordination across both legs, both hemispheres of the brain and a stream of real-time environmental information. A constant, unchanging level of stimulation cannot adapt to that complexity and, in some cases, may even suppress the natural neural signals the brain needs to coordinate movement effectively.

To address that gap, Wang and her team developed a personalized adaptive DBS system, or aDBS, with findings published in Nature Medicine. Unlike conventional DBS, which relies on a fixed setting determined in a clinic visit, this system uses surface electrodes placed on the brain to detect specific biomarkers associated with the moment a patient is about to take a step with the left or right leg. The device captures these sub-second signals and rapidly adjusts the level of stimulation delivered to each hemisphere of the brain in real time, increasing or decreasing it in coordination with each phase of the gait cycle.

Critically, those adjustments are embedded directly into the implanted neurostimulator itself, meaning the system can respond automatically without requiring ongoing manual adjustment. Wang describes achieving that level of rapid, coordinated, hemisphere-specific responsiveness as a significant technical achievement, one that fundamentally distinguishes this approach from traditional DBS.

For patients living with Parkinson's disease, particularly those struggling with gait instability and falls that have not responded to conventional treatment, this adaptive approach represents a meaningful shift, moving deep brain stimulation from a static, one-size-fits-all setting toward a responsive system that moves with the patient rather than simply suppressing the noise around them.